PET imaging in oncology
R Bar-Shalom, AY Valdivia, MD Blaufox - Seminars in nuclear medicine, 2000 - Elsevier
The role of positron emission tomography (PET) during the past decade has evolved rapidly
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …
FDG-PET for clinical use: results of the 3rd German Interdisciplinary Consensus Conference," Onko-PET III", 21 July and 19 September 2000
SN Reske, J Kotzerke - European journal of nuclear medicine, 2001 - Springer
Positron emission tomography (PET) is the most powerful molecular imaging technique
currently available for clinical use. Because deranged tumour metabolism is a common …
currently available for clinical use. Because deranged tumour metabolism is a common …
Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion
H Schoder, HWD Yeung, M Gonen, D Kraus… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To compare diagnostic accuracy of attenuation-corrected positron emission
tomography (PET) with fused PET and computed tomography (CT) in patients with head and …
tomography (PET) with fused PET and computed tomography (CT) in patients with head and …
From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology
K Kubota - Annals of nuclear medicine, 2001 - Springer
Cancer cells show increased metabolism of both glucose and amino acids, which can be
monitored with 18 F-2-deoxy-2-fluoro-d-glucose (FDG), a glucose analogue, and 11 Cl …
monitored with 18 F-2-deoxy-2-fluoro-d-glucose (FDG), a glucose analogue, and 11 Cl …
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma
DL Schwartz, E Ford, J Rajendran, B Yueh… - International Journal of …, 2005 - Elsevier
PURPOSE: Image localization of head-and-neck squamous cell carcinoma lags behind
current techniques to deliver a precise radiation dose with intensity-modulated radiotherapy …
current techniques to deliver a precise radiation dose with intensity-modulated radiotherapy …
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature …
M Buglione, R Cavagnini, F Di Rosario… - Critical reviews in …, 2016 - Elsevier
Radiotherapy alone or in combination with chemotherapy and/or surgery is the typical
treatment for head and neck cancer patients. Acute side effects (such as oral mucositis …
treatment for head and neck cancer patients. Acute side effects (such as oral mucositis …
Diagnostic accuracy of follow-up FDG PET or PET/CT in patients with head and neck cancer after definitive treatment: a systematic review and meta-analysis
S Sheikhbahaei, M Taghipour… - American Journal of …, 2015 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to assess the diagnostic performance of FDG
PET or PET/CT for detection of local, regional, and distant recurrences in the follow-up of …
PET or PET/CT for detection of local, regional, and distant recurrences in the follow-up of …
FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review
T Liu, W Xu, WL Yan, M Ye, YR Bai, G Huang - Radiotherapy and Oncology, 2007 - Elsevier
PURPOSE: To perform a systematic review to compare FDG-PET, CT, and MRI imaging for
diagnosis of local residual or recurrent nasopharyngeal carcinoma. MATERIALS AND …
diagnosis of local residual or recurrent nasopharyngeal carcinoma. MATERIALS AND …
Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma
Purpose: Plasma Epstein-Barr virus DNA (pEBV DNA) is an important prognostic marker in
nasopharyngeal carcinoma (NPC). This study tested the hypotheses that pEBV DNA reflects …
nasopharyngeal carcinoma (NPC). This study tested the hypotheses that pEBV DNA reflects …
Fluorodeoxyglucose–positron-emission tomography imaging of head and neck squamous cell cancer
The hybrid technique of PET/CT has significantly impacted the imaging and management of
HNSCC since its introduction in 2001 and has become the technique of choice for imaging …
HNSCC since its introduction in 2001 and has become the technique of choice for imaging …